VISIBLE ALPHA LAUNCHES NEW BIOPHARMA PLATFORM

The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before. This demand is amplified by evolving regulations, diverse clinical trial outcomes and frequent market fluctuations.  The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before...

The pharmaceutical and biotech industries deliver constant innovation and are rapidly evolving. The demand for accurate and holistic drug-level forecasts is more important than ever before. This demand is amplified by evolving regulations, diverse clinical trial outcomes and frequent market fluctuations. 

With the launch of Visible Alpha BioPharma, Visible Alpha is providing investment professionals and drug developers with a one-stop-shop for comprehensive drug data and granular financial information to swiftly identify new opportunities, evaluate market competitiveness, gauge market expectations, analyze historical data, access forward-looking estimates and conduct rapid analysis at the drug level.

Visible Alpha's new BioPharma platform will allow investment, equity research, and drug development professionals to:

"According to the FDA, we are experiencing a faster pace of innovation and development and more drug approvals in the pharmaceutical and biotech industries," said Mark Hale, CEO of Visible Alpha. "In creating Visible Alpha's BioPharma platform, we are enabling investment professionals the ability to not only keep pace, but to enhance the speed of strategic investment decision making through granular financial information on thousands of drugs – all in an interactive platform that allows for exploration and discovery. We are thrilled to bring this incredibly robust and feature rich platform to our clients."

The new Visible Alpha BioPharma platform features the following functionality:

Today's announcement follows recent news of Visible Alpha's continued growth of sell-side institution contributors. Learn more >

About Visible Alpha

Visible Alpha enhances the investment research process by extracting meaningful value from key sell-side assets, including analyst models, research reports and corporate access events through partnerships with the world's premier investment research organizations. Our deep consensus data provides granular and timely insights into the sell-side view of companies, industries and peer groups. For more information, visit visiblealpha.com.

Media Contact: Erin Gifford
erin.gifford@visiblealpha.com

Logo - https://mma.prnewswire.com/media/2334517/Visible_Alpha_Logo.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/visible-alpha-launches-new-biopharma-platform-302053931.html